Test Code Proca G Procainamide and N-Acetylprocainamide, Serum
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged and the serum aliquoted into a plastic vial within 2 hours of collection.
Useful For
Monitoring therapy with procainamide
Assessing compliance
Evaluating procainamide toxicity
Method Name
Homogeneous Enzyme Immunoassay
Reporting Name
Procainamide and NAPA, SSCH Clinical System Name: Procainamide Group
Specimen Type
SerumSpecimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Frozen (preferred) | 14 days | |
Refrigerated | 7 days | ||
Ambient | 24 hours |
Reject Due To
Gross hemolysis | Reject |
Reference Values
Procainamide
Therapeutic: 4.0-10.0 mcg/mL
Critical value: >12.0 mcg/mL
N-acetylprocainamide
Therapeutic: 12.0-18.0 mcg/mL
Critical value: ≥40.0 mcg/mL
Method Description
These assays are based on a homogeneous enzyme immunoassay technique. The assay is a competition assay between the drug in the sample and drug labeled with the enzyme glucose-6-phosphate dehydrogenase (G6PD) for antibody binding sites. Enzyme activity decreases upon binding to the antibody, so the drug concentration in the sample can be measured in terms of enzyme activity. Active enzyme converts oxidized nicotinamide adenine dinucleotide (NAD) to NADH, resulting in an absorbance change that is measured spectrophotometrically. Endogenous serum G6PD does not interfere because the coenzyme functions only with the bacterial (Leuconostoc mesenteroides) enzyme employed in the assay.(Package inserts: Procainamide and N-acetylprocainamide. Roche Diagnostics; 08/2015)
Day(s) Performed
Monday through Saturday
Report Available
Same day/1 to 2 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
80192
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
PA | Procainamide and NAPA, S | 3983-4 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
8683 | Procainamide, S | 3982-6 |
2461 | N-acetylprocainamide, S | 3834-9 |
2462 | Procainamide + NAPA | 3983-4 |
Forms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.